🇺🇸 FDA
Pipeline program

Hemodialysis with Polymethylmethacrylate Artificial Kidney

DMR95-IRB-79

Approved other completed

Quick answer

Hemodialysis with Polymethylmethacrylate Artificial Kidney for Uremia is a Approved program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Uremia
Phase
Approved
Modality
other
Status
completed

Clinical trials